Published in Vaccine Weekly, October 11th, 1999
The United Kingdom has recently announced a mass group C meningococcal vaccination program that is expected to include NeisVac- C.
Dr. Peter Richmond of the U.K.'s Public Health Laboratory Service (PHLS) presented results of a comparative toddler clinical trial for group C meningococcal conjugate vaccines at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting in San Francisco, California, held late September.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly